Efficacy and safety of different anti-osteoporotic drugs for the spinal fusion surgery: A network meta-analysis

Figure 2 Network meta-analysis of fusion rate between risedronate, teriparatide, teriparatide combined with denosumab, zoledronic acid, alendronate and placebo. A: Network structure diagram of fusion rate; B: Heterogeneity of the included studies; C: Forest plot of the fusion rate of the drugs compared with placebo; D: Surface under the cumulative ranking curve of different drugs for fusion rate.